RxDoctor Payments DataLook up a doctor →

Samta Bhakta

Adult Health · Morrisville, NCNPI 1770712846

Payments from drug & device makers

$10,629in general payments, 2019–2025

Across 493 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$2K
  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$758
  • Livanova USA, Inc.$575
  • Novartis$574
  • Abbott$572
  • plus $5K from 38 others

What the payments were for

  • Travel & lodging$2182%
  • Food & beverage$10,35697%
  • Education$551%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,629 in reported general payments places this provider in the 95th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$59,941
Medicare patients
105
Services billed
1,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate270$123,067
Nurtec OdtRimegepant Sulfate48$92,620
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen614$69,723
BelbucaBuprenorphine Hcl62$53,373
Buprenorphine144$49,471
NucyntaTapentadol Hcl24$44,279
LinzessLinaclotide61$36,243
ZtlidoLidocaine25$23,140
Nucynta ErTapentadol Hcl35$22,080
MovantikNaloxegol Oxalate41$21,358
Hysingla ErHydrocodone Bitartrate19$15,256
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl70$11,931
OxycontinOxycodone Hcl31$11,864
HorizantGabapentin Enacarbil12$10,445
Lidocaine57$9,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta, Nucynta Er$566$242,799391 claims
PfizerNurtec Odt$402$92,62048 claims
AbbVieLinzess$1,162$36,24361 claims
Scilex Pharmaceuticals Inc.Ztlido$1,627$23,14025 claims
Redhill Biopharma Inc.Movantik$111$21,35841 claims
Arbor Pharmaceuticals, Inc.Horizant$60$10,44512 claims
Almatica Pharma LLCGralise$89$9,58012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 614 adult health providers in North Carolina.

Other adult health in Morrisville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →